![](https://porib.com/wp-content/uploads/2021/07/European-Stroke-Journal.jpg)
de Andrés-Nogales F, Álvarez M, de Miquel MÁ, Segura T, Gil A, Cardona P, Casado MÁ, Nogueira RG, Davalos A
Cost-effectiveness of mechanical thrombectomy using stent retriever after intravenous t-PA compared with intravenous t-PA alone in the treatment of acute ischaemic stroke due to large vessel occlusion in Spain
Eur Stroke J 2017. Vol. 2(3) 272–284
![](https://porib.com/wp-content/uploads/2021/07/gastroenterologia_y_hepatologia.jpg)
Turnes J, Domínguez-Hernández R, Casado MÁ
Análisis coste-efectividad de dos estrategias de tratamiento para la hepatitis C crónica: antes y después del acceso a los agentes antivirales de acción directa en España
Gastroenterol Hepatol. 2017;40(7):433-446
MÁS INFORMACIÓN
![](https://porib.com/wp-content/uploads/2021/07/nutricion_hospitalaria.jpg)
Burgos R, Virgili MN, Cuerda MC, Moreno JM, Olveira G, Luengo LM, Wanden-Berghe C, Muñoz A, Torres C, Casado MA
Estimación del coste de la nutrición parenteral domiciliaria en España
Nutr Hosp. 2017; 34(2):271-276
![](https://porib.com/wp-content/uploads/2021/07/journal_viral_hepatitis.jpg)
Buti M, Domínguez-Hernández R, Oyagüez I, Casado MA, Esteban R
Cost-effectiveness analysis of ledipasvir/sofosbuvir in patients with chronic hepatitis c: treatment of patients with absence or mild fibrosis compared to patients with advanced fibrosis
J Viral Hepat 2017;24(9):750-758
![](https://porib.com/wp-content/uploads/2021/07/Annals-of-Hepatology-.jpg)
Oyagüez I, Buti M, Brosa M, Rueda M, Casado MA
Cost-effectiveness and clinical impact of antiviral strategies of HBeAg-positive and -negative chronic hepatitis B
Ann Hepatol 2017;16(3):358-65
![](https://porib.com/wp-content/uploads/2021/06/pharmacoeconomics_spanish_research_articles-1.jpg)
de Andrés-Nogales F, Oyagüez I, Alvarez-Sala LA, García-Bragado F, Navarro A, González P, Elías I, Soto J